HealthcareOn the MoveFDA accepts Zalviso NDADec. 02, 2013 7:45 AM ETTalphera, Inc. (TLPH) StockTLPHBy: Colin Lokey, SA News Editor The FDA accepts AcelRx's (NASDAQ:ACRX) NDA for Zalviso. CEO Richard King is "extremely pleased." (PR) ACRX +1.2% premarket (+11% last Friday). Recommended For YouMore Trending NewsSee More »About TLPH StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgTLPH--Talphera, Inc.Trending AnalysisTrending News